NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Shell Companies · USD

Research Alliance Corporation III (RACC) Stock Analysis

Research Alliance Corporation III (RACC) is a Shell Companies stock listed on NASDAQ and quoted in US Dollar.

RACC

$11.44

−$0.93 (−7.52%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare RACC with… →

RACC Key Statistics

As of Sep 4, 2026
Trading
Open
$12.26
Previous Close
$12.37
Day's Range
11.18–12.74
52-Week Range
10.21–33.50
Volume
1.07M
Valuation
Market Cap
$104.09M
Financials (FY)
Profit marginThe share of revenue left as profit after all costs and taxes.
0.00%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
7.78M
Dividend and dates
Avg Volume
46.86K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

RACC Valuation vs Shell Companies Median

Median of 587 stocks
MetricRACCShell Companies medianvs median
Profit margin0.00%0.00%0.0 pts above

Medians across 587 Shell Companies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Research Alliance Corporation III (RACC) carries a market capitalisation of $104.09M. The company sits in the Financial Services sector, in the Shell Companies industry.

The 52-week range on file runs from $10.21 to $33.50. RACC last closed at $11.44 on September 4, 2026. That is −$0.93 (−7.52%) against the previous close. The latest close sits 12.05% above that 52-week low.

Financial Health

Profit margin runs at 0%.

Growth & Income

No dividend is on file for RACC.

2026 is still running; the price is +11.07% year to date.

Peer Comparison

Research Alliance Corporation III (RACC) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Research Alliance Corporation III RACC $104.09M —
Churchill Capital Corp XI CCXI $746.38M —
Churchill Capital Corp X CCCX $711.00M —
Drugs Made In America Acquisition II Corp. DMII $647.83M 35.1

The Shell Companies industry average P/E ratio is 45.2x. Research Alliance Corporation III has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Shell Companies Stocks

CCXI

Churchill Capital Corp XI

$746.38M

 CCCX

Churchill Capital Corp X

$711.00M

 DMII

Drugs Made In America Acquisition II Corp.

$647.83M

 BCSS

Bain Capital GSS Investment Corp.

$602.40M

 EVAC

EQV Ventures Acquisition Corp. II

$602.01M

 CXII

Churchill Capital Corp XII

$594.94M
View all Shell Companies stocks →

Popular Financial Services Stocks

BRK-B

Berkshire Hathaway Inc.

$1.08T

 JPM

JPMorgan Chase & Co.

$953.33B

 V

Visa Inc.

$700.27B

 MA

Mastercard Incorporated

$507.39B

 BAC

Bank of America Corporation

$438.31B
View all Financial Services stocks →

About Research Alliance Corporation III

Research Alliance Corporation III focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was incorporated in 2026 and is based in New York, New York.